MONTREAL, QUEBEC – Pfizer Canada has made a $600,000 gift to the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) via McGill University and the McGill University Health Centre (MUHC) Foundation. The gift, which was announced today during the 2nd annual MI4 Scientific Symposium, will support innovation and life-changing research through the creation of the Pfizer Early Career Investigator Awards.

Classified as: MI4
Published on: 4 Dec 2020

By Meaghan Thurston (Office of Research and Innovation)

Classified as: Highly cited
Published on: 18 Nov 2020

By Shawn Hayward

Six McGill University Faculty of Medicine and Health Sciences researchers — Boris Bernhardt, Mark Brandon, Yasser Iturria-Medina, Jean-Francois Poulin, Jo Anne Stratton and Masha Prager-Khoutorsky — have received grants to support their work in the early-career stage, after being chosen from 150 talented applicants.

Brain Canada’s Future Leaders in Canadian Brain Research Program, anchored by a $5M gift from the Azrieli Foundation, enables paradigm-changing research of the brain to improve the lives of all Canadians.

Classified as: funding, Brain Canada
Published on: 12 Nov 2020

Five projects led by McGill University researchers are included among the 79 receiving a total of $28 million in research infrastructure support through the Canada Foundation for Innovation (CFI) Exceptional Opportunities Fund. The announcement was made today by the Honourable Navdeep Bains, Minister of Innovation, Science and Industry during a news conference this morning.

Classified as: Faculty of Medicine and Health Sciences, Faculty of Science, COVID 19, CFI
Published on: 6 Nov 2020

Earlier today, a Quebec based consortium of research institutes (Génome Québec, Oncopole and IVADO) announced the winners of their first-ever “Omics Data Against Cancer” competition, and McGill research teams were dominant. In fact, of the five selected teams no less than four of them included professors from McGill.

Classified as: omics, genomics, AI, Cancer, Awards
Published on: 5 Nov 2020

Earlier today, the Quebec government announced the winners of its annual Prix du Quebec competition, a series of 15 awards in science and culture. Among them was Professor William Foulkes, Head of the Cancer Genetics Laboratory at the Lady Davis Institute, a member of the Cancer Research Program of the Research Institute of the McGill University Health Centre, and Director of the Program in Cancer Genetics at McGill University. Dr.

Published on: 4 Nov 2020

Changing makeup of a specific protein has the potential to neutralize the virus

Researchers from McGill University are part of an international team led by the University of Buffalo, which has discovered a technique that could help increase the effectiveness of vaccines against SARS-CoV-2, the virus that causes COVID-19. The group’s study was published recently online in the journal Advanced Materials.

Classified as: covid-19
Published on: 4 Nov 2020

Using a new technique, a team of McGill University researchers has found tiny and previously undetectable ‘hot spots’ of extremely high stiffness inside aggressive and invasive breast cancer tumours. Their findings suggest, for the first time, that only very tiny regions of a tumor need to stiffen for metastasis to take place. Though still in its infancy, the researchers believe that their technique may prove useful in detecting and mapping the progression of aggressive cancers.

Classified as: Faculty of Engineering, breast cancer, Research, Rosalind and Morris Goodman Cancer Research Centre, faculty of medicine
Published on: 27 Oct 2020

COVID-19 Resources Canada, a grassroots organization co-founded by a McGill researcher, today announced it received a donation of $250,000 from the Trottier Family Foundation to facilitate Canada’s response to the pandemic. Since its launch in March 2020, the organization has developed two of the most comprehensive databases in Canada with more than 600 COVID-19 funded research projects and experts from over 25 Canadian institutions.

Classified as: covid-19, Research during COVID-19, faculty of medicine
Published on: 26 Oct 2020

As countries struggle to contain the COVID-19 pandemic, vaccination uptake is a public health priority now more than ever. Efforts to increase vaccinations vary greatly around the globe. A new McGill-led study comparing policies around the world finds broad implementation of mandatory vaccination mandates. However, the penalties for failing to vaccinate differ significantly by country, ranging from fines to jail time.

Classified as: Mandatory, vaccinations, policy, penalties, countries, global, health, Nicole Basta, Katie Gravagna
Published on: 22 Oct 2020

A McGill-led multi-institutional research team has discovered that during memory consolidation, there are at least two distinct processes taking place in two different brain networks – the excitatory and inhibitory networks. The excitatory neurons are involved in creating a memory trace, and the inhibitory neurons block out background noise and allow long-term learning to take place.

Classified as: faculty of medicine, Research, Long-term memory
Published on: 7 Oct 2020

Trust in public institutions is linked to fewer COVID-19 deaths, but trust and belonging to groups is associated with more deaths, according to a wide-ranging, McGill-led study of 30-day COVID-19 mortality rates in 84 countries. Greater economic inequality is also associated with COVID-19 mortality.

Classified as: covid-19, trust, income inequality, social capital, Frank Elgar
Published on: 7 Oct 2020

A new study examining the link between peanut and tree-nut anaphylaxis in children and holidays found spikes at Halloween and Easter. The study, led by a team of researchers from the Montreal Children’s Hospital of the McGill University Health Centre (MCH-MUHC), found that most were previously unknown allergies, calling for increased awareness.

Classified as: nut, peanut, allergies, allergy, anaphylaxis, risk, Montreal Children’s Hospital, McGill University Health Centre, Melanie Leung, Moshe Ben-Shoshan
Published on: 5 Oct 2020

Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published recently in the Journal of General Internal Medicine, a McGill-led team published the results of a recent survey of 28 experts working in vaccinology.

Classified as: faculty of medicine, Reserch, covid-19, Vaccine, Jonathan Kimmelman
Published on: 1 Oct 2020

Researchers at McGill University are part of a major international study to better understand the cause and effect of psychosis in adolescents and young adults who are at risk for this condition. The research, which is being led by the Department of Psychiatry at Yale University, will be funded by a $52 million grant from the National Institutes of Health (NIH).

Classified as: NIH, Psychosis, Department of Psychiatry
Published on: 24 Sep 2020

Pages

Back to top